Atherogenic index of plasma is an independent predictor of metabolic-associated fatty liver disease in patients with type 2 diabetes

MLA

Sahar Samimi, et al. “Atherogenic Index of Plasma Is an Independent Predictor of Metabolic-Associated Fatty Liver Disease in Patients with Type 2 Diabetes.” European Journal of Medical Research, vol. 27, no. 1, July 2022, pp. 1–7. EBSCOhost, https://doi.org/10.1186/s40001-022-00731-x.

APA

Sahar Samimi, Sahar Rajabzadeh, Soghra Rabizadeh, Manouchehr Nakhjavani, Pooria Nakhaei, Foroogh Alborzi Avanaki, & Alireza Esteghamati. (2022). Atherogenic index of plasma is an independent predictor of metabolic-associated fatty liver disease in patients with type 2 diabetes. European Journal of Medical Research, 27(1), 1–7. https://doi.org/10.1186/s40001-022-00731-x

Chicago

Sahar Samimi, Sahar Rajabzadeh, Soghra Rabizadeh, Manouchehr Nakhjavani, Pooria Nakhaei, Foroogh Alborzi Avanaki, and Alireza Esteghamati. 2022. “Atherogenic Index of Plasma Is an Independent Predictor of Metabolic-Associated Fatty Liver Disease in Patients with Type 2 Diabetes.” European Journal of Medical Research 27 (1): 1–7. doi:10.1186/s40001-022-00731-x.